| View |
|
DRP-9351-01
|
Granisetron (hydrochloride)
|
Grani-Ace
|
1 mg/mL (3 mg/3 mL)
|
Solution for I.V. Injection or Infusion
|
Antiemetic and Antinauseant (Serotonin (5HT3) antagonist)
|
Mefar Ilac Sanayii A.S.
|
Turkey
|
-
|
26 January 2022
|
04 December 2025
|
| View |
|
DRP-10475-02
|
Telmisartan
|
Elzar 40
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Globela Pharma Private Limited
|
India
|
-
|
26 January 2022
|
30 September 2026
|
| View |
|
DRP-10481-01
|
Mefenamic Acid
|
None
|
500 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Fortis Medi Pharmaceutical, Inc
|
Philippines
|
Renewal
|
20 June 2022
|
19 September 2027
|
| View |
|
DRP-5025-43
|
Omeprazole (as sodium
|
FADZflux
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump (H+K+ATPase) Inhibitor
|
Shreechem Pharmaceuticals Pvt. Ltd
|
India
|
Renewal
|
04 August 2023
|
27 December 2028
|
| View |
|
DRP-7359-10
|
Spironolactone
|
Zydactin 25
|
25 mg
|
Tablet
|
Diuretic
|
Maxtar Bio-Genics
|
India
|
-
|
22 January 2022
|
04 October 2026
|
| View |
|
DRP-10763-01
|
Dutasteride + Tamsulosin hydrochloride
|
Astedart
|
500 mcg/ 400 mcg
|
Capsule
|
Alpha-adrenoreceptor Antagonists
|
Globela Pharma Private Limited
|
India
|
-
|
22 January 2022
|
16 November 2026
|
| View |
|
DRP-8265-01
|
Citicoline (as sodium)
|
Calyxin
|
1 g
|
Extended Release Tablet
|
Nootropic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
|
India
|
Renewal
|
15 June 2024
|
13 May 2030
|
| View |
|
DRP-10511-11
|
Febuxostat
|
Lesurix 80
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
21 January 2022
|
07 October 2026
|
| View |
|
BRP-097-01
|
Enoxaparin sodium
|
Emoxin
|
6,000 IU/0.6 mL (60 mg/0.6 mL)
|
Solution for Injection (SC)
|
Anticoangulant
|
Hangzhou Jiuyuan Gene Engineering Co. Ltd
|
China
|
-
|
20 January 2022
|
04 April 2025
|
| View |
|
DRP-11045
|
Paracetamol + Caffeine
|
Acetaffein
|
500mg/65mg
|
Tablet
|
Analgesic/Antipyretic
|
Saga Lifesciences Limited
|
India
|
-
|
18 January 2022
|
15 October 2026
|
| View |
|
DRP-7329-01
|
Olanzapine
|
None
|
15 mg
|
Orally Disintegrating Tablet
|
Antipsychotic
|
Cadila Healthcare Limited
|
India
|
-
|
14 January 2022
|
14 May 2025
|
| View |
|
DRP-9961-01
|
Risperidone
|
None
|
1 mg
|
Tablet
|
Antipsychotic
|
Cadila Healthcare Limited
|
India
|
Renewal
|
15 June 2022
|
04 September 2027
|
| View |
|
DRP-9999-01
|
Irbesartan
|
None
|
300 mg
|
Film-Coated Tablet
|
Angiontensin-II Receptor Antagonist
|
Cadila Healthcare Limited
|
India
|
Renewal
|
16 May 2022
|
20 June 2027
|
| View |
|
BRP-101
|
Epoetin Alfa
|
Epokine
|
4,000 IU/mL
|
Solution for Injection (IV/SC)
|
-
|
HK inno.N Corporation
|
Korea
|
-
|
07 January 2022
|
20 October 2026
|
| View |
|
BRP-102
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Epokine
|
10,000 IU/mL
|
Solution for Injection (IV/SC)
|
HEMATOPOIETIC GROWTH FACTOR
|
HK inno.N Corporation
|
Korea
|
Renewal
|
23 November 2022
|
24 January 2028
|
| View |
|
HRP-315-02
|
Dichlorobenzyl Alcohol + Amylmetacresol
|
Unbranded
|
1.2 mg/600 mcg
|
Lozenge (Orange Flavor)
|
Antiseptic
|
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
Renewal
|
20 March 2024
|
24 April 2029
|
| View |
|
DRP-1791-06
|
Clopidogrel
|
Milopid 75
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
10 May 2024
|
17 August 2029
|
| View |
|
DRP-5060-04
|
Cefuroxime (as Sodium)
|
Cerox
|
750 mg
|
Powder for Injection
|
Antibacterial
|
Zhuhai Kinhoo Pharmaceutical Co., Ltd
|
China
|
-
|
07 January 2022
|
14 October 2026
|
| View |
|
DRP-6454-01
|
Bisacodyl
|
None
|
5 mg
|
Enteric-Coated Tablet
|
Laxative
|
Mediwin Pharmaceuticals
|
India
|
-
|
07 January 2022
|
09 December 2025
|
| View |
|
DRP-6949-03
|
Omeprazole
|
Gemzole-20
|
20 mg
|
Delayed Release Capsule
|
Proton Pump Inhibitor
|
Kopran Limited
|
India
|
-
|
07 January 2022
|
14 December 2026
|